Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy.

Trial Profile

Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Rituximab (Primary) ; Adalimumab; Etanercept
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms ORBIT
  • Most Recent Events

    • 28 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 18 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
    • 14 Dec 2013 Accrual to date is 112% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top